Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Therapeutic Effect of Astaxanthin Isolated from Xanthophyllomyces dendrorhous Mutant Against Naproxen-Induced Gastric Antral Ulceration in Rats

  • KIM JEONG-HWAN (Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University) ;
  • KIM SEUNG-WOOK (Department of Chemical and Biological Engineering, Korea University) ;
  • YUN CHEOL-WON (Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University) ;
  • CHANG HYO-IHL (Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University)
  • Published : 2005.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Frequently used for humans as a nonsteroidal anti-inflammatory drug, naproxen has been known to induce ulcerative gastric lesions. The present study was undertaken to investigate the in vivo therapeutic effect of astaxanthin, isolated from a Xanthophyllomyces dendrorhous mutant, against naproxen-induced gastric antral ulceration in rats. The rats were treated with three doses of astaxanthin [1, 5, and 25 mg/kg body weight (B.W.), respectively] once daily for 2 weeks after pretreatment of 80 mg of naproxen/kg B.W. twice daily for 3 days, while the control rats received only 80 mg of naproxen/kg B.W. twice daily for 3 days. The oral administration of astaxanthin (1,5, and 25 mg/kg B.W.) showed a curative effect against naproxen (80 mg/kg B.W.)-induced gastric antral ulcer and reduced the elevated lipid peroxide level in gastric mucosa. In addition, astaxanthin treatment resulted in significant increase in the activities of radical scavenging enzymes such as superoxide dismutase, catalase, and glutathione peroxidase. A histologic examination clearly proved that acute gastric mucosal lesion induced by naproxen nearly disappeared after the astaxanthin treatment. These results suggest that astaxanthin eliminated the lipid peroxides and free radicals induced by naproxen and may be a potential candidate for remedy of gastric ulceration.

Keywords

References

  1. Aebi, H. 1974. In H. U. Bergmeyer (ed.). Methods of Enzymatic Analysis. pp. 674-678. Academic Press, New York, U.S.A
  2. Andrew, A. G., H. J. Phaff, and M. P. Starr. 1976. Carotenoids of Phaffia rhodozyma, a red pigmented fermenting yeast. Phytochemistry 15: 1003 - 1007 https://doi.org/10.1016/S0031-9422(00)84390-3
  3. An, G. H., D. B. Schuman, and E. A. Johnson. 1989. Isolation of Phaffia rhodozyma mutants with increased astaxanthin content. Appl. Environ. Microbiol. 55: 116-124
  4. Beck, W. S., H. T. Schneider, K. Dietzel, B. Nuernberg, and K. Brune. 1990. Gastrointestinal ulcerations induced by antiinflammatory drugs in rats. Arch. Toxicol. 64: 210-217 https://doi.org/10.1007/BF02010727
  5. Bendich, A. and J. A. Olson. 1989. Biological actions of carotenoides. FASEB J. 3: 1927 -1932 https://doi.org/10.1096/fasebj.3.8.2656356
  6. Bjarnason, I., J. Hayllar, A. J. MacPherson, and A. Russell. 1993. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104: 1832-1847 https://doi.org/10.1016/0016-5085(93)90667-2
  7. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254 https://doi.org/10.1016/0003-2697(76)90527-3
  8. Calhoun, W., S. C. Gilman, L. J. Datko, T. W. Copenhaver, and R. P. Carlson. 1992. Interaction studies of tilomisole, aspirin and naproxen in acute and chronic inflammation with assessment of gastrointestinal irritancy in the rat. Agents Actions 36: 99-106 https://doi.org/10.1007/BF01991236
  9. Cioli, V., S. Putzolu, V. Rossi, B. P. Scorza, and C. Corradino. 1979. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol. Appl. Pharmacol. 50: 283-289 https://doi.org/10.1016/0041-008X(79)90153-4
  10. Hogeboom, G. H. 1955. In S. P. Colowick and N. O. Kaplan (eds.). Methods in Enzymology, pp. 16-19. Academic Press, New York, U.S.A
  11. Johnson, E. A. and M. J. Lewis. 1979. Astaxanthin formation by the yeast Phaffia rhodozyma. J. Gen. Microbiol. 115: 173-183 https://doi.org/10.1099/00221287-115-1-173
  12. Jyonouchi, H., L. Zhang, M. Gross, and Y. Tomita. 1994. Immunomodulating actions of carotenoids: Enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr. Cancer 21: 47-58 https://doi.org/10.1080/01635589409514303
  13. Jyonouchi, H., S. Sun, K. Lijima, and M. D. Gross. 2000. Antitumor activity of astaxanthin and its mode of action. Nutr. Cancer 36: 59-65 https://doi.org/10.1207/S15327914NC3601_9
  14. Kim, J. H., C. W. Kim, and H. I. Chang. 2004. Screening and characterization of red yeast Xanthophyllomyces dendrorhous mutants. J. Microbiol. Biotechnol. 14: 570-575
  15. Kim, J. H., S. K. Choi, W. J. Lim, and H. I. Chang. 2004. Protective effect of astaxanthin produced by Xanthophyllomyces dendrorhous mutant on indomethacin-induced gastric mucosal injury in rats. J. Microbiol. Biatechnol. 14: 996-1003
  16. Kim, S. J., G. J. Kim, D. H. Park, and Y. W. Ryu. 2003. High-level production of astaxanthin by fed-batch culture of mutant strain Phaffia rhodozyma AJ-6-1. J. Microbiol. Biotechnol. 13: 175-181
  17. Krinsky, N. I. 1989. Antioxidant function of carotenoids. Free Radic. Biol. Med. 7: 617-635 https://doi.org/10.1016/0891-5849(89)90143-3
  18. Kurashige, M., E. Okimasu, M. Inoue, and K. Utsumi. 1990. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol. Chem. Physics Med. NMR 22: 27-38
  19. Lanza, F. L. 1984. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am. J. Med. 13: 1924
  20. Lawrence, R. A. and R. F. Burk. 1976. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 71: 952-958 https://doi.org/10.1016/0006-291X(76)90747-6
  21. Lewis, M. J., N. Ragot, M. C. Berlant, and M. Miranda. 1990. Selection of astaxanthin-overproducing mutants of Phaffia rhodozyma with ${\beta}$-ionone. Appl. Environ. Microbiol. 56: 2944-2945
  22. Lim, B. P., A. Nagao, J. Terao, K. Tanaka, T. Suzuki, and K. Takama. 1992. Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation. Biochim. Biophys. Acta 1126: 178-184 https://doi.org/10.1016/0005-2760(92)90288-7
  23. McCarthy, D. M. 1990. NSAID-induced gastro-intestinal damage - a critical review of prophylaxis and therapy. J. Clin. Gastroenterol. 12: S13-S20 https://doi.org/10.1097/00004836-199000000-00004
  24. McCarthy, D. M. 1995. Mechanisms of mucosal injury and healing: The role of nonsteroidal anti-inflammatory drugs. Scand. J. Gastroenterol. 208: 24-29
  25. McCord, J. M. and J. Fridovich. 1967. Superoxide dismutase, an enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244: 6049-6055
  26. Mortensen, A., L. H. Skibsted, and T. G. Truscott. 2001. The interaction of dietary carotenoids with radical species. Arch. Biochem. Biophys. 385: 13 - 19 https://doi.org/10.1006/abbi.2000.2172
  27. Naguib, Y. M. 2000. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 48: 1150-1154 https://doi.org/10.1021/jf991106k
  28. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358 https://doi.org/10.1016/0003-2697(79)90738-3
  29. Okai, Y. and K. Higashi-Okai. 1996. Possible immunomodulating activities of carotenoids in in vitro cell culture experiments. Int. J. Immunopharmacol. 18: 753-758 https://doi.org/10.1016/S0192-0561(97)85558-0
  30. Palozza, P. and N. I. Krinsky. 1992. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 297: 291-295 https://doi.org/10.1016/0003-9861(92)90675-M
  31. Parks, D. A. 1989. Oxygen radicals: Mediators of gastrointestinal pathophysiology. Gut 30: 293-298 https://doi.org/10.1136/gut.30.3.293
  32. Roth, S. H. and R. E. Bennett. 1987. Non-steroidal anti-inflammatory drug gastropathy: Recognition and response. Arch. Intern. Med. 147: 2093-2100 https://doi.org/10.1001/archinte.147.12.2093
  33. Sedmak, J. J., D. K. Weerasinghe, and S. O. Jolly. 1990. Extraction and quantitation of astaxanthin from Phaffia rhodozyma. Biotech. Tech. 4: 107-112 https://doi.org/10.1007/BF00163282
  34. Sun, N. K., S. H. Lee, G. H. Ahn, M. S. Won, and K. B. Song. 2002. Low-dose gamma irradiation as means of isolating carotenoid-hyperproducing yeast mutant. J. Microbiol. Biotechnol. 12: 1010-1012
  35. Suwa, T., H. Urano, Y. Kohno, A. Suzuki, and T. Amano. 1987. Comparative studies on the gastrointestinal lesions caused by several nonsteroidal anti-inflammatory agents in rats. Agents Actions 21: 167-172 https://doi.org/10.1007/BF01974937
  36. Tanaka, T., T. Kawamori, M. Ohnishi, H. Makita, H. Mori, K. Satoh, and A. Hara. 1995. Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls, astaxanthin and canthaxanthin, during the postinitiation phase. Carcinogenesis 16: 2957-2963 https://doi.org/10.1093/carcin/16.12.2957
  37. Tanaka, T., H. Makita, M. Ohnishi, H. Mori, K. Satoh, and A. Hara. 1995. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 55: 4059-4064
  38. Tanaka, T., Y. Morishita, M. Suzuki, T. Kojima, A. Okumura, and H. Mori. 1994. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 15: 15-19 https://doi.org/10.1093/carcin/15.1.15
  39. Tenenbaum, J. 1999. The epidemiology of nonsteroidal anti-inflammatory drugs. Can. J. Gastroenterol. 13: 119-122
  40. Yoshikawa, T., Y. Naito, S. Ueda, H. Oyamada, T. Takemura, N. Yoshida, S. Sugino, and M. Kondo. 1990. Role of oxygen-derived free radicals in the pathogenesis of gastric mucosal lesions in rats. J. Clin. Gastroenterol. 12: 65-71 https://doi.org/10.1097/00004836-199001001-00012